Reumofan Plus Dietary Supplement Found to Contain Potentially Harmful Ingredients Which Were Not Listed on Label

The US Food & Drug Administration is warning consumers that Reumofan Plus contains several active pharmaceutical ingredients not listed on the label that could be harmful. A lab test of the medication, which is a natural dietary supplement for pain relief and other serious conditions, concluded it contained Diclofenac Sodium. The following is from the FDA press release on the topic of Diclofenac Sodium:

Diclofenac Sodium, a prescription non-steroidal anti-inflammatory drug (NSAID) that may cause increased risk of cardiovascular events such as heart attack and stroke, as well as serious gastrointestinal (GI) adverse events including bleeding, ulceration, and fatal perforation (causing a hole) of the stomach and intestines, and Methocarbamol, a prescription muscle relaxant that can cause sedation, dizziness, low blood pressure, and impair mental or physical abilities to perform tasks such as driving a motor vehicle or operating machinery.

The FDA has been receiving reports of adverse events from the use of Reumofan Plus, including liver injury, sudden worsening of glucose control, weight gain, swelling, leg cramps, and adrenal suppression.

If you are currently taking Reumofan Plus or have taken it in the past, please talk with your doctor immediately.

Additional Reading: